ethinyl estradiol
Sponsors
National Center for Research Resources (NCRR), National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID), Eli Lilly and Company, Wyeth is now a wholly owned subsidiary of Pfizer
Conditions
Advanced MalignanciesEndometrial CancerHIV InfectionsHealthy volunteersOverweightOvulationSystemic Lupus ErythematosusTurner Syndrome
Phase 1
Bioequivalence of Trienor
Active, not recruitingRPCEC00000265
Start: 2018-08-01Target: 72Updated: 2026-03-30
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
CompletedNCT06039826
Start: 2023-09-12End: 2024-07-11Updated: 2024-07-26
A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies
Not yet recruitingNCT07340190
Start: 2026-05-29End: 2028-04-07Target: 24Updated: 2026-04-02
Phase 2
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
CompletedNCT00033358
Start: 2002-02-28Updated: 2013-05-03
Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation
CompletedNCT00254189
Start: 2002-12-31End: 2004-10-31Target: 60Updated: 2006-05-19
Phase 3
Unknown Phase
Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
CompletedNCT00006133
Start: 2000-06-30Target: 970Updated: 2005-06-24
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
CompletedNCT00042289
Start: 2003-06-09End: 2020-09-30Updated: 2025-12-02